GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Herpes Zoster

Phase 3

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

CompletedNCT02581410

GlaxoSmithKlineHerpes Zoster

Start: 2015-12-15End: 2017-08-01Updated: 2018-08-28

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

CompletedNCT02979639

GlaxoSmithKlineHerpes Zoster

Start: 2017-01-16End: 2018-05-24Updated: 2019-10-08

Related Papers

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

The Journal of Infectious Diseases2020-02-2521 citations

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine

Open Forum Infectious Diseases2019-10-01

Evaluation of two frailty indices, with practical application in a vaccine clinical trial

Human Vaccines & Immunotherapeutics2019-06-0312 citations

2488. The Impact of Reactogenicity After Administration of the Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults

Open Forum Infectious Diseases2018-11-011 citations

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-of-Study Results of a Phase III, Group-Matched, Clinical Trial

Open Forum Infectious Diseases2018-11-01

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

The Journals of Gerontology Series A2018-09-2533 citations

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

The Journal of Infectious Diseases2017-09-1372 citations

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial

Open Forum Infectious Diseases2017-01-015 citations